Perrotta Peter L, Bahou Wadie F
Stony Brook University Hospital, 7300 SUNY Nicolls Road, Stony Brook, NY, 11794, USA.
Curr Hematol Rep. 2004 Nov;3(6):462-9.
Proteomics, the rapid large-scale analysis of cellular proteins, is becoming an important tool in the study of human platelet biology. A number of investigators have used proteomics techniques to study platelets including two-dimensional gel electrophoresis, protein separation, and mass spectrometry protein identification. Most efforts have focused on: 1) cataloging the spectrum of proteins that comprise the normal platelet "proteome", 2) characterizing proteins released from activated platelets, and 3) identifying phosphoproteins generated upon platelet stimulation. The incorporation of modern proteomics technology to platelet studies will further our understanding of platelet activation, adhesion, and aggregation at the protein level. Moreover, proteomics offers hope that novel biomarkers can be discovered that diagnose inherited and/or acquired platelet disorders, or predict the susceptibility of such individuals to bleeding or thrombosis. Finally, proteomics could lead to identification of novel agents that have therapeutic value. This review discusses the current status and future opportunities of proteomics technologies in platelet science.
蛋白质组学,即对细胞蛋白质进行快速大规模分析,正成为研究人类血小板生物学的一项重要工具。许多研究人员已使用蛋白质组学技术来研究血小板,包括二维凝胶电泳、蛋白质分离和质谱蛋白质鉴定。大多数研究工作集中在:1)编目构成正常血小板“蛋白质组”的蛋白质谱,2)表征活化血小板释放的蛋白质,以及3)鉴定血小板刺激后产生的磷酸化蛋白质。将现代蛋白质组学技术应用于血小板研究将在蛋白质水平上进一步加深我们对血小板活化、黏附和聚集的理解。此外,蛋白质组学有望发现可诊断遗传性和/或获得性血小板疾病,或预测此类个体出血或血栓形成易感性的新型生物标志物。最后,蛋白质组学可能会导致鉴定出具有治疗价值的新型药物。本文综述了蛋白质组学技术在血小板科学中的现状和未来机遇。